NCT07507331Completed
Turkish Version of the Neurogenic Bladder Symptom Score Short Form
Turkish Version of the Neurogenic Bladder Symptom Score Short Form: Cross-Cultural Adaptation and Validation-Reliability Study
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
This observational study aims to evaluate the cross-cultural adaptation and psychometric properties of the Turkish version of the Neurogenic Bladder Symptom Score Short Form (NBSS-SF) in adults with spinal cord injury or multiple sclerosis who have neurogenic lower urinary tract dysfunction. Neurogenic bladder symptoms, such as urinary incontinence, urgency, and difficulties with urine storage or emptying, may negatively affect daily functioning and quality of life. In this study, the validity and reliability of the Turkish NBSS-SF will be examined, and convergent validity will be assessed through its relationship with the King's Health Questionnaire (KHQ) and the Short Form-12 (SF-12). In eligible participants, the scale will be administered again after 7 to 14 days. The aim of the study is to provide a valid and reliable Turkish patient-reported outcome measure for use in clinical practice and research.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 120 (actual)
- First submitted
- 27 Mar 2026
- Start date
- 27 Mar 2026
- Primary completion date
- 22 Jul 2026
- Lead sponsor
- Gaziantep Islam Science and Technology University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07507331
What you commit to
- Study type: Observational
- Participants enrolled: 120
- From 27 Mar 2026 to the primary completion date, 22 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having undergone urological surgery in the last month
- Reporting changes in bladder/urinary function between the first and second applications (surgery, UTI, change in bladder medication)
Other illness
- Having an active urinary tract infection (UTI)
Other
- Having a significant recent change in general health status
- Having a spinal cord injury (SCI) in the spinal shock phase
- Having experienced a relapse of Multiple Sclerosis (MS) within the last 3 months.
Who the study is looking for
- Being ≥18 years old
- Having a diagnosis of Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) and neurogenic lower urinary tract dysfunction
- Being able to read and understand Turkish and have the cognitive ability to independently complete questionnaires
- Can be included with any bladder management method (spontaneous voiding, CIC, permanent catheter, condom catheter, reconstruction/diversion etc.)
- Volunteering and signing informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Hospital, Neurology Outpatient Clinic and Viransehir State Hospital, Urology Outpatient Clinic Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.